{"id":169166,"date":"2025-07-17T06:07:40","date_gmt":"2025-07-17T10:07:40","guid":{"rendered":"https:\/\/44.250.171.167\/?p=169166"},"modified":"2025-07-17T06:07:40","modified_gmt":"2025-07-17T10:07:40","slug":"glaxosmithkline-pharmaceuticals-ltd-q4fy25-36-rise-in-profits-2","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q4fy25-36-rise-in-profits-2\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals Ltd Q4FY25; 36% rise in Profits"},"content":{"rendered":"<p>GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)<\/p>\n<p>Financial Results:<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b9974.00 Crores up from \u20b9930.00 Crore year on year, a rise of 4.73%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b9657.00 Crores down from \u20b9692.00 Crores year on year, a fall of 5.06%.<\/p>\n<p>Consolidated Net Profit of \u20b9263.00 Crores up 35.57% from \u20b9194.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b915.52, up 35.19% from \u20b911.48 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-169167\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b9974.00 Crores up from \u20b9930.00 Crore year on year, a rise of 4.73%. Total Expenses for Q4FY25 of \u20b9657.00 Crores down from \u20b9692.00 Crores year [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":169167,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-169166","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-10.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169153,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q4fy25-36-rise-in-profits\/","url_meta":{"origin":169166,"position":0},"title":"Glaxosmithkline Pharmaceuticals Ltd Q4FY25; 36% rise in Profits","author":"Divyansh_Kasana","date":"July 16, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b9974.00 Crores up from \u20b9930.00 Crore year on year, a rise of 4.73%. Total Expenses for Q4FY25 of \u20b9657.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165642,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q2fy25-16-rise-in-profits\/","url_meta":{"origin":169166,"position":1},"title":"Glaxosmithkline Pharmaceuticals Ltd Q2FY25; 16% rise in Profits","author":"Divyansh_Kasana","date":"November 14, 2024","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q2FY25 of \u20b91,011.00 Crores up from \u20b9957.00 Crore year on year, a rise of 5.64%. Total Expenses for Q2FY25 of \u20b9706.00 Crores up from \u20b9686.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/GLAXO.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167751,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q3fy25-400-rise-in-profits\/","url_meta":{"origin":169166,"position":2},"title":"Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits","author":"Divyansh_Kasana","date":"April 4, 2025","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b9949.00 Crores up from \u20b9805.00 Crore year on year, a rise of 17.89%. Total Expenses for Q3FY25 of \u20b9677.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/H-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157252,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q2fy24-13-rise-in-profits\/","url_meta":{"origin":169166,"position":3},"title":"Glaxosmithkline Pharmaceuticals Ltd Q2FY24; 13% rise in Profits","author":"Divyansh_Kasana","date":"December 12, 2023","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b9957.00 Crores up from \u20b9917.00 Crore year on year, a rise of 4.36%. Total Expenses for Q2FY24 of \u20b9686.00 Crores up from \u20b9676.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-80.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":163732,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q1fy25-38-rise-in-profits\/","url_meta":{"origin":169166,"position":4},"title":"Glaxosmithkline Pharmaceuticals Ltd Q1FY25; 38% rise in Profits","author":"Divyansh_Kasana","date":"August 9, 2024","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q1FY25 of \u20b9815.00 Crores up from \u20b9762.00 Crore year on year, a rise of 6.96%. Total Expenses for Q1FY25 of \u20b9600.00 Crores down from \u20b9634.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-62.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":149910,"url":"https:\/\/alphastreet.com\/india\/glaxosmithkline-pharmaceuticals-ltd-q1-fy24-11-rise-in-profits\/","url_meta":{"origin":169166,"position":5},"title":"Glaxosmithkline Pharmaceuticals Ltd Q1 FY24; 11% rise in Profits","author":"Hardik Bhandare","date":"July 26, 2023","format":false,"excerpt":"GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results: Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9762.00 Crores up from \u20b9745.00 Crore year on year, a rise of 2.28%. Total Expenses for Q1FY24 of \u20b9634.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-225.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=169166"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169166\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/169167"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=169166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=169166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=169166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}